Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices

Tissue Engineering - Part C: Methods

Volumn 21, Issue 8, 2015, Pages 795-807

  Duan, Bin ^a   Hockaday, Laura A ^a   Das, Shoshana ^b   Xu, Charlie ^b   Butcher, Jonathan T ^a  

^a School of Operations Research and Industrial Engineering   (United States)

^b Department of Biological and Environmental Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; BONE; CELL CULTURE; FIBROBLASTS; HYDROGELS; PEDIATRICS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

AORTIC HEART VALVES; BASIC FIBROBLAST GROWTH FACTOR; EXTRACELLULAR MATRIX REMODELING; HEART VALVE TISSUE ENGINEERINGS; MATRIX REMODELING; MESENCHYMAL STEM CELL; OSTEOGENIC DIFFERENTIATION; THREEDIMENSIONAL (3-D);

CELL ENGINEERING;

FIBROBLAST GROWTH FACTOR 2; VIMENTIN;

ADIPOSE TISSUE; AORTA VALVE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID; HYDROGEL; LEYDIG CELL; MESENCHYMAL STEM CELL; PEDIATRIC AORTIC VALVE INTERSTITIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; UPREGULATION; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CHILD; COMPARATIVE STUDY; CYTOLOGY; FEMALE; MALE; MESENCHYMAL STROMA CELL; METABOLISM;

AORTIC VALVE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 84937859614     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2014.0589     Document Type: Article

References (82)

1. Nkomo, V.T., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., and Enriquez-Sarano, M.Burdenofvalvular heart diseases: a population-based study. Lancet 368, 1005, 2006.
2. Gandaglia, A., Bagno, A., Naso, F., Spina, M., and Gerosa, G. Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Eur J Cardio-Thorac Surg 39, 523, 2011.
3. Cheung, A., Webb, JG., Barbanti, M., Freeman, M., Binder, R.K., Thompson, C., et al. 5-Year experience with trans-catheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol 61, 1759, 2013.
4. Sacks, M.S., Schoen, F.J., and Mayer, J.E.J. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 11, 289, 2009.
5. Butcher, J.T., Mahler, G.J., and Hockaday, L.A. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev 63, 242, 2011.
6. Shinoka, T., Breuer, C.K., Tanel, R.E., Zund, G., Miura, T., Ma, P.X., et al. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Cardiovasc Surg 60, S513, 1995.
7. Steinhoff, G., Stock, U., Karim, N., Mertsching, H., Timke, A., Meliss, R.R., et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits-in vivo restoration of valve tissue. Circulation 102, 50, 2000.
8. Flanagan, T.C., Sachweh, J.S., Frese, J., Schnoring, H., Gronloh, N., Koch, S., et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15, 2965, 2009.
9. Schmidt, D., Stock, U.A., and Hoerstrup, S.P. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Trans R Soc B-Biol Sci 362, 1505, 2007.
10. Bader, A., Schilling, T., Teebken, O.E., Brandes, G., Herden, T., Steinhoff, G., et al. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardio-Thorac Surg 14, 279, 1998.
11. Hoffman-Kim, D., Maish, M.S., Krueger, P.M., Lukoff, H., Bert, A., Hong, T., et al. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. Tissue Eng 11, 288, 2005.
12. Weber, B., Emmert, M.Y., and Hoerstrup, S.P. Stem cells for heart valve regeneration. Swiss Med Wkly 142, w13622, 2012.
13. Rippel, R.A., Ghanbari, H., and Seifalian, A.M. Tissue-engineered heart valve: future of cardiac surgery. World J Surg 36, 1581, 2012.
14. Weber, B., Emmert, M.Y., Behr, L., Schoenauer, R., Bro-kopp, C., Drogemuller, C., et al. Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials 33, 4031, 2012.
15. Perry, T.E., Kaushal, S., Sutherland, F.W.H., Guleserian, K.J., Bischoff, J., Sacks, M., et al. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg 75, 761, 2003.
16. Dijkman, P.E., Driessen-Mol, A., Frese, L., Hoerstrup, S.P., and Baaijens, F.P.T. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno-and homografts. Biomaterials 33, 4545, 2012.
17. Syedain, Z.H., Bradee, A.R., Kren, S., Taylor, D.A., and Tranquillo, R.T. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A 19, 759, 2013.
18. Weber, B., Scherman, J., Emmert, M.Y., Gruenenfelder, J., Verbeek, R., Bracher, M., et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur Heart J Suppl. 32, 2830, 2011.
19. Colazzo, F., Sarathchandra, P., Smolenski, R.T., Chester, A.H., Tseng, Y.T., Czernuszka, J.T., et al. Extracellular matrix production by adipose-derived stem cells: implications for heart valve tissue engineering. Biomaterials 32, 119, 2011.
20. Aikawa, E., Whittaker, P., Farber, M., Mendelson, K., Pa-dera, R.F., Aikawa, M., et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult-Implications for postnatal adaptation, pathology, and tissue engineering. Circulation 113, 1344, 2006.
21. Yip, C.Y.Y., and Simmons, C.A. The aortic valve micro-environment and its role in calcific aortic valve disease. Cardiovasc Pathol 20, 177, 2011.
22. Stephens, E.H., Chu, C.K., and Grande-Allen, K.J. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: Relevance to an age-specific tissue-engineered heart valve. Acta Biomater 4, 1148, 2008.
23. Latif, N., Sarathchandra, P., Thomas, P.S.A., Batten, P., Chester, A.H., Taylor, P.M., et al. Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells. J Heart Valve Dis 16, 56, 2007.
24. Butcher, J.T., and Nerem, R.M. Porcine aortic valve interstitial cells in three-dimensional culture: Comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis 13, 478, 2004.
25. Chen, J.H., Yip, C.Y.Y., Sone, E.D., and Simmons, C.A. Identification and characterization of aortic valve mesen-chymal progenitor cells with robust osteogenic calcification potential. Am J Pathol 174, 1109, 2009.
26. Wirrig, E.E., Hinton, R.B., and Yutzey, K.E. Differential expression of cartilage and bone-related proteins in pedi-atric and adult diseased aortic valves. J Mol Cell Cardiol 50, 561, 2011.
27. Duan, B., Hockaday, L.A., Kapetanovic, E., Kang, K.H., and Butcher, J.T. Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels. Acta Biomater 9, 7640, 2013.
28. Duan, B., Kapetanovic, E., Hockaday, L.A., and Butcher, J.T. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells. Acta Biomater 10, 1836, 2014.
29. Mahler, G.J., Farrar, E.J., and Butcher, J.T. Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells. Arterioscler Thromb Vasc Biol 33, 121, 2013.
30. Ferdous, Z., Jo, H., and Nerem, R.M. Strain magnitude-dependent calcific marker expression in valvular and vascular cells. Cells Tissues Organs 197, 372, 2013.
31. Ferdous, Z., Jo, H., and Nerem, R.M. Differences in valvular and vascular cell responses to strain in osteogenic media. Biomaterials 32, 2885, 2011.
32. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., and Chen, C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6, 483, 2004.
33. Kern, S., Eichler, H., Stoeve, J., Kluter, H., and Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294, 2006.
34. Chiang, H.S., Hsieh, C.H., Lin, Y.H., Lin, S.M., Tsai-Wu, J.J., and Jiang, C.C. Differences between chondrocytes and bone marrow-derived chondrogenic cells. Tissue Eng Part A 17, 2919, 2011.
35. Duan, B., Hockaday, L.A., Kang, K.H., and Butcher, J.T. 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res Part A 101A, 1255, 2013.
36. Richards, J., El-Hamamsy, I., Chen, S., Sarang, Z., Sar-athchandra, P., Yacoub, M.H., et al. Side-specific endo-thelial-dependent regulation of aortic valve calcification interplay of hemodynamics and nitric oxide signaling. Am J Pathol 182, 1922, 2013.
37. Edwards, C.A., and Obrien, W.D. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104, 161, 1980.
38. Jin, R., Teixeira, L.S.M., Dijkstra, P.J., van Blitterswijk, C.A., Karperien, M., and Feijen, J. Enzymatically-cross-linked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials 31, 3103, 2010.
39. Butcher, J.T., Norris, R.A., Hoffman, S., Mjaatvedt, C.H., and Markwald, R.R. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 302, 256, 2007.
40. Rabkin, E., Aikawa, M., Stone, J.R., Fukumoto, Y., Libby, P., and Schoen, F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104, 2525, 2001.
41. Quinlan, A.M.T., and Billiar, K.L. Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation. J Biomed Mater Res Part A 100A, 2474, 2012.
42. Kruzynska-Frejtag, A., Machnicki, M., Rogers, R., Mark-wald, R.R., and Conway, S.J. Periostin (an osteoblast-spe-cific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 103, 183, 2001.
43. Snider, P., Hinton, R.B., Moreno-Rodriguez, R.A., Wang, J., Rogers, R., Lindsley, A., et al. Periostin is required for maturation and extracellular matrix stabilization of non-cardiomyocyte lineages of the heart. Circ Res 102, 752, 2008.
44. Norris, R.A., Moreno-Rodriguez, R.A., Sugi, Y., Hoffman, S., Amos, J., Hart, M.M., et al. Periostin regulates atrio-ventricular valve maturation. Dev Biol 316, 200, 2008.
45. Zeisberg, E.M., Tarnavski, O., Zeisberg, M., Dorfman, A.L., McMullen, J.R., Gustafsson, E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952, 2007.
46. Taylor, P.M., Allen, S.P., and Yacoub, M.H. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis 9, 150, 2000.
47. Halfon, S., Abramov, N., Grinblat, B., and Ginis, I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 20, 53, 2011.
48. Rice, J.J., Martino, M.M., De Laporte, L., Tortelli, F., Briquez, P.S., and Hubbell, J.A. Engineering the regenerative microenvironment with biomaterials. Adv Healthc Mater 2, 57, 2013.
49. Saik, J.E., Gould, D.J., Watkins, E.M., Dickinson, M.E., and West, J.L. Covalently immobilized platelet-derived growth factor-BB promotes antiogenesis in biomirnetic poly(ethylene glycol) hydrogels. Acta Biomater 7, 133, 2011.
50. Leslie-Barbick, J.E., Moon, J.J., and West, J.L. Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels. J Biomater Sci-Polym Ed 20, 1763, 2009.
51. DeLong, S.A., Moon, J.J., and West, J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 26, 3227, 2005.
52. Zhao, R.G., Sider, K.L., and Simmons, C.A. Measurement of layer-specific mechanical properties in multilayered biomaterials by micropipette aspiration. Acta Biomater 7, 1220, 2011.
53. Taylor, P.A., Batten, P., Brand, N.J., Thomas, P.S., and Yacoub, M.H. The cardiac valve interstitial cell. Int J Biochem Cell Biol 35, 113, 2003.
54. Chester, A.H., and Taylor, P.M. Molecular and functional characteristics of heart-valve interstitial cells. Philosophical Trans R Soc B-Biol Sci 362, 1437, 2007.
55. DiGirolamo, C.M., Stokes, D., Colter, D., Phinney, D.G., Class, R., and Prockop, D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107, 275, 1999.
56. Li, Z.L., Liu, C.X., Xie, Z.H., Song, P.Y., Zhao, R.C.H., Guo, L., et al. Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. Plos One 6, e20526, 2011.
57. Wall, M.E., Bernacki, S.H., and Loboa, E.G. Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng 13, 1291, 2007.
58. Tseng, P.C., Young, T.H., Wang, T.M., Peng, H.W., Hou, S.M., and Yen, M.L. Spontaneous osteogenesis of MSCs cultured on 3D microcarriers through alteration of cyto-skeletal tension. Biomaterials 33, 556, 2012.
59. Cloyd, K.L., El-Hamamsy, I., Boonrungsiman, S., Hede-gaard, M., Gentleman, E., Sarathchandra, P., et al. Characterization of porcine aortic valvular interstitial cell 'calcified' nodules. Plos One 7, e48154, 2012.
60. Poggio, P., Sainger, R., Branchetti, E., Grau, J.B., Lai, E.K., Gorman, R.C., et al. Noggin attenuates the osteogenic activation of human valve interstitial cells in aortic valve sclerosis. Cardiovasc Res 98, 402, 2013.
61. Fisher, C.I., Chen, J., and Merryman, W.D. Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent. Biomech Model Mechanobiol 12, 5, 2013.
62. Rodriguez, K.J., Piechura, L.M., and Masters, K.S. Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol 30, 70, 2011.
63. Han, L., and Gotlieb, A.I. Fibroblast growth factor-2 promotes in vitro mitral valve interstitial cell repair through transforming growth factor-beta/smad signaling. Am J Pa-thol 178, 119, 2011.
64. Han, L., and Gotlieb, A.I. Fibroblast growth factor-2 promotes in vitro heart valve interstitial cell repair through the Akt1 pathway. Cardiovasc Pathol 21, 382, 2012.
65. Gotlieb, A.I., Rosenthal, A., and Kazemian, P. Fibroblast growth factor 2 regulation of mitral valve interstitial cell repair in vitro. J Thorac Cardiovasc Surg 124, 591, 2002.
66. Sewell-Loftin, M.K., Chun, Y.W., Khademhosseini, A., and Merryman, W.D. EMT-inducing biomaterials for heart valve engineering: Taking cues from developmental biology. J Cardiovasc Transl Res 4, 658, 2011.
67. Chen, H.C., Zhu, Y.T., Chen, S.Y., and Tseng, S.C.G. Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition. Lab Invest 92, 676, 2012.
68. Narine, K., De Wever, O., Van Valckenborgh, D., Francois, K., Bracke, M., Desmet, S., et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng 12, 2707, 2006.
69. Somers, P., Cornelissen, R., Thierens, H., and van Nooten, G. An optimized growth factor cocktail for ovine mesen-chymal stem cells. Growth Factors 30, 37, 2012.
70. Song, T., Wang, W.J., Xu, J., Zhao, D., Dong, Q., Li, L., et al. Fibroblast growth factor 2 inhibits bone morphoge-netic protein 9-induced osteogenic differentiation of mes-enchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2. Int J Biochem Cell Biol 45, 1639, 2013.
71. Biver, E., Soubrier, A.S., Thouverey, C., Cortet, B., Broux, O., Caverzasio, J., et al. Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells. Biochem Biophys Res Commun 427, 737, 2012.
72. Sohier, J., Carubelli, I., Sarathchandra, P., Latif, N., Chester, A.H., and Yacoub, M.H. The potential of anisotropic matrices as substrate for heart valve engineering. Bioma-terials 35, 1833, 2014.
73. Tedder, M.E., Simionescu, A., Chen, J., Liao, J., and Si-mionescu, D.T. Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering. Tissue Eng Part A 17, 25, 2011.
74. Sierad, L.N., Simionescu, A., Albers, C., Chen, J., Maive-lett, J., Tedder, M.E., et al., Design and testing of a pulsatile conditioning system for dynamic endothelialization of polyphenol-stabilized tissue engineered heart valves. Cardiovasc Eng Tech 1, 138, 2010.
75. Leslie-Barbick, J.E., Shen, C., Chen, C., and West, J.L. Micron-scale spatially patterned, covalently immobilized vascular endothelial growth factor on hydrogels accelerates endothelial tubulogenesis and increases cellular angiogenic responses. Tissue Eng Part A 17, 221, 2011.
76. Alt, E., Yan, Y.S., Gehmert, S., Song, Y.H., Altman, A., Gehmert, S., et al. Fibroblasts share mesenchymal pheno-types with stem cells, but lack their differentiation and colony-forming potential. Biol Cell 103, 197, 2011.
77. Hinton, R.B., and Yutzey, K.E. Heart valve structure and function in development and disease. Annu Rev Physiol 73, 29, 2011.
78. Schoen, F.J. Mechanisms of fuction and disease of natural and replacement heart valves. Annu Rev Pathol-Mech Dis 7, 161, 2012.
79. Chen, J.H., and Simmons, C.A. Cell-matrix interactions in the pathobiology of calcific aortic valve disease critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res 108, 1510, 2011.
80. Hamilton, A.M., Boughner, D.R., Drangova, M., and Rogers, K.A. Statin treatment of hypercholesterolemic-induced aortic valve sclerosis. Cardiovasc Pathol 20, 84, 2011.
81. Stephens, E.H., Saltarrelli, J.G., Baggett, L.S., Nandi, I., Kuo, J.J., Davis, A.R., et al. Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardio-vasc Pathol 20, 334, 2011.
82. Bailey, M.T., Pillarisetti, S., Xiao, H., and Vyavahare, N.R. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res Part A 66A, 93, 2003.